Navigation Links
Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results
Date:8/29/2012

INDIANAPOLIS, Aug. 29, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the decision to stop ongoing clinical studies investigating pomaglumetad methionil, also known as mGlu2/3, for the treatment of patients suffering from schizophrenia. The decision was made after a recently conducted independent futility analysis concluded HBBN, the second of Lilly's two pivotal studies, was unlikely to be positive in its primary efficacy endpoint if enrolled to completion. The decision was not based on any safety signals.

Additionally, the recently completed Phase II study, HBCO, which investigated pomaglumetad methionil as an adjunctive treatment with atypical antipsychotics, did not meet its primary endpoint. 

Lilly is contacting study investigators to outline specific actions related to the close-out of each ongoing study. Lilly will work with study investigators to ensure an appropriate transition of study participants to continuing clinical care outside of the trials.

"I'm disappointed in what these results mean for patients with schizophrenia who still are searching for options to treat this terrible illness," said Jan Lundberg, Ph.D., executive vice president, science and technology, and president, Lilly Research Laboratories.  "While there are many challenges in this complex field of research, neuroscience remains a core area of focus at Lilly. Our clinical development pipeline includes nearly a dozen neuroscience molecules being studied to treat illnesses such as depression, bipolar disorder and cognitive impairment associated with schizophrenia."

The decision to stop ongoing Phase III development of pomaglumetad methionil is expected to result in a third-quarter charge to R&D expense in the range of $25 million to $30 million (pre-tax), or approximately $0.02 per share (after-tax).  The company's previously-iss
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. U.S. Court of Appeals Upholds Validity of Lillys Alimta Compound Patent
2. Lilly Revises 2012 Reported Guidance to Reflect Income from Early Payment of Amylin Obligations
3. Lilly Announces Study Results Regarding Postmenopausal Women with Back Pain Caused by Vertebral Fractures
4. Lilly Supports Research to Determine What a Dogs Nose Knows About People with Diabetes and Severe Hypoglycemia
5. Lilly Reports Second-Quarter 2012 Results, Raises 2012 EPS Guidance
6. Lilly Confirms Date and Conference Call for Second-Quarter 2012 Financial Results Announcement
7. Lilly Announces Pomaglumetad Methionil Did Not Meet Primary Endpoint of Clinical Study
8. Lilly Diabetes Announces Once Upon A Time Contest Winner
9. Lilly Statement on Affordable Care Act Ruling by Supreme Court
10. Lilly Statement on PDUFA Vote by Senate
11. PrimeraDx Announces Commencement of Product Development Collaboration with Eli Lilly and Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  Cephasonics, ... platform, today announced the introduction of the ... complete network-based communications with all cQuest Ultrasound™ ... embedded-ultrasound technology, including this new capability, at ... Paulo, Brazil from May 21-24.  ...
(Date:5/21/2013)... 2013 iHealth Lab Inc., a pioneer ... healthcare products and a powerful integrated mobile app ... of two new fitness products to its existing ... the Wireless Pulse Oximeter and Wireless Activity and ... iHealth Lab is also excited ...
(Date:5/21/2013)... Hurel Corporation ("Hurel"), a world-leading provider of ... today announced the appointment of James S. ... of Directors. Dr. MacDonald is the former Executive Vice ... ("SPRI"), which was the pharmaceutical development arm of Schering ... in 2009. Over a career that has ...
Breaking Medicine Technology:Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
... Cardica, Inc. (Nasdaq: CRDC ) ... General Surgery at the Red Cross Hospital Clementinenhaus, ... laparoscopic procedures using Cardica,s, proprietary Microcutter XPRESS™ 30 ... several sigmoidectomies, an appendectomy and a small intestinal ...
... , For the fourth year, the Fondation,Médéric ... for evidence-based psychosocial,interventions for people with dementia and their ... care and share best,practices. Applications can be submitted from ... http://www.alz.co.uk/award . Psychosocial research involves or ...
Cached Medicine Technology:Dr. Andreas Kuthe Performs First Laparoscopic Procedures Using Cardica's Microcutter XPRESS™ 30 Surgical Cutting and Stapling Device 2Dr. Andreas Kuthe Performs First Laparoscopic Procedures Using Cardica's Microcutter XPRESS™ 30 Surgical Cutting and Stapling Device 34th Alzheimer's Awards Announced in Search of Global Solutions for Better Dementia Care 2
(Date:5/21/2013)... Nearly 40 Platinum Supplemental Insurance ... trip in Los Cabos, Mexico, Feb. 23-March 1, 2013, to ... elderly. , The facility serves meals and provides a social ... Cabo, Mexico. , Platinum Vice President, Mike Muench, says that ... company’s history. , “Platinum got its start selling long-term ...
(Date:5/21/2013)... Dallas, Tx. (PRWEB) May 21, 2013 ... first peer- reviewed journal article testing the efficacy of ... symptoms of eczema. The clinical study results appear in ... , The article, “A Novel Sodium Hypochlorite Cleanser ... of Atopic Dermatitis,” reports impressive findings seen after consistent ...
(Date:5/21/2013)... 21, 2013 Access MediQuip, LLC ... management company, announced today that it has expanded its ... the nation's largest health benefits companies, with more than ... approximately 66 million individuals served through its subsidiaries. , ... surgical implant management program agreement back in 2008. Under ...
(Date:5/21/2013)... Everspark Interactive, one of the city's leading online ... the past year – and announced another milestone this ... efforts for Kids II, a designer of innovative baby ... local effort, specializing in search engine optimization (SEO) or ... website. The company now offers a host of boutique ...
(Date:5/21/2013)... Dimensional Insight, a developer of business intelligence ... Maryland Health System, a 275-bed hospital based in ... to help it analyze its data more quickly. Western ... Diver through Dimensional Insight’s recently announced partnership with ... Maryland has massive amounts of data in disparate systems, ...
Breaking Medicine News(10 mins):Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 3Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 2Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 3Health News:Access MediQuip and WellPoint Renew and Expand National Contract for Implantable Medical Devices 2Health News:Access MediQuip and WellPoint Renew and Expand National Contract for Implantable Medical Devices 3Health News:Everspark Named Interactive Marketing Company for Kids II 2Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 2Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 3
... (BRONX, NY) Researchers at the Albert Einstein College ... first time that cancers can be successfully treated by ... published in the October 31 issue of PloS One, ... virus-infected cells before they turn cancerous. , The Einstein ...
... BioMed Realty Trust, Inc.,(NYSE: BMR ) today announced ... 30, 2007 after the market closes on Wednesday, November ... Officer, and Kent Griffin,Chief Financial Officer, will host an ... November 8, 2007 to discuss the company,s,financial results and ...
... SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP ) announced today ... conferences during which Mike Grey, president & chief,executive officer ... Company,s oncology pipeline. The conference information is as,follows: ... at 9:00 AM Pacific Daylight ...
... 30 PharmAthene, Inc., a leading,biodefense company specializing ... chemical and biological terrorism,announced today that it is ... /,Acumen BioFin 9th Annual Healthcare Conference on Tuesday, ... for the Company will be David P.,Wright, President ...
... LOS ANGELES Healthcare providers have observed it for years ... life while battling their cancer live longer. Now, a ... with locally advanced non-small cell lung backs that observation. ... other classic predictors of survival. , In the past, weve ...
... Virus Shows Promise as Metastatic Cancer Treatment , ... and can differentiate between normal and cancerous cells. The ... cancers, such as small-cell lung cancer. , Cancer-killing viruses ... therapies for localized cancer. But so far their success ...
Cached Medicine News:Health News:Einstein scientists treat cancer as an infectious disease -- with promising results 2Health News:Einstein scientists treat cancer as an infectious disease -- with promising results 3Health News:BioMed Realty Trust to Report 2007 Third Quarter Results 2Health News:SGX Pharmaceuticals to Present at Three Upcoming Investor Conferences 2Health News:Quality of life: most important predictor of survival for advanced NSCLC patients 2Health News:Other highlights in the Oct. 30 JNCI 2Health News:Other highlights in the Oct. 30 JNCI 3Health News:Other highlights in the Oct. 30 JNCI 4
Long-Sleeve Bolero for targeted compression in the upper arms, upper back and shoulder areas. Plush-shielded hook and eye front closure for comfort and convenient application....
Velcro® closure, uniform contour compression, available as 9" and 12" bands for abdominal support, 9" can be used as a breast wrap....
Sub Pectoral Breast Augmentation Wrap...
CDIs Ultra-Comfort Bra™ is designed with special single needle stitching that places the cup seams away from critical surgical sites....
Medicine Products: